Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT00554372 2016-02-04

A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma

Phase 2 Completed

30 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms